lifestyle.pluralist.com

CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML

Written by

CHARM Therapeutics raises $80 million in Series B financing to advance development of best-in-class menin inhibitor for AML – NEWSnet – News… as it used to be

More Press Releases

April 16, 2026

Stonly Launches Knowledge Agents to Keep Customer Service Knowledge Current, Accurate, and AI-Ready

April 16, 2026

From a San Francisco Sidewalk to a Counselor’s Office: New Memoir “Finishing Stronger” Tells the Improbable True Story of Ronnie M. Palmer

April 16, 2026

APPLIED Adhesives Named a 3M Preferred Adhesive Distributor

April 16, 2026

2026 Hyundai Elantra N TCR Edition Offers Compelling Pricing